Work

A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.114

Authors: Eric Jay Small, Raymond Lance, Thomas A. Gardner, Lawrence Ivan Karsh, Andrew Stubbs, Candice McCoy, Todd DeVries, Charles H. Redfern, Neal D. Shore

Institutions: University of California, San Francisco, Eastern Virginia Medical School, Indiana University School of Medicine, The Urology Center of Colorado, Dendreon (United States), Carolina Urologic Research Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590489941

Cites:

Cited by: 18

Related to: 10